HO-1 expression increases outside the prostate tumors as a result of the HO-1+ macrophage synthesis, which was correlated with the presence of bone metastases, suggesting that extra tumoral elevation of HO-1 could serve as a potential biomarker for PCa bone metastases [27]. Here, HMOX1 is linked to prostate neoplasm.